GTHP.US Guided Therapeutics Inc

Healthcare Health Care Equipment & Supplies USA Stocks
0.1100 USD
Close of Nov 14, 2026
0.1000 0.5400
Market cap
USD 10.6M
P/E
-
P/B
106.31x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.

Is GTHP.US undervalued?

Graham number

The Graham number of Guided Therapeutics Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Guided Therapeutics Inc fundamental analysis

No fundamental analysis for Guided Therapeutics Inc yet.

Guided Therapeutics Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Guided Therapeutics Inc

Guided Therapeutics, Inc., a medical technology company, researches, develops, tests, manufactures, sells, and distributes medical devices in the United States and internationally. It offers LuViva, an advanced cervical scan non-invasive cervical cancer detection device that provides less invasive and painless alternative to conventional tests for identifying, screening, and detecting cervical cancers and precancers. The company was formerly known as SpectRx, Inc. and change…

Full company profile